O
39
6
SO
77
4
OI
32
2
DNB
38
4
MHK
43
-9
WY
31
6
HBAN
39
5
BDX
46
-6
STT
40
4
SPG
64
3
SE
52
12
VZ
35
3
ITW
59
4
TAP
40
3
CI
58
13
PVH
70
2
KIM
51
10
CHRW
44
2
VNO
42
2
DIS
44
4
O
39
6
SO
77
4
OI
32
2
DNB
38
4
MHK
43
-9
WY
31
6
HBAN
39
5
BDX
46
-6
STT
40
4
SPG
64
3
SE
52
12
VZ
35
3
ITW
59
4
TAP
40
3
CI
58
13
PVH
70
2
KIM
51
10
CHRW
44
2
VNO
42
2
DIS
44
4
Financhill
Back

Calidi Biotherapeutics 10K Form

Sell
43

CLDI
Calidi Biotherapeutics

Last Price:
0.19
Seasonality Move:
-13.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLDI News And Ratings

See the #1 stock for the next 7 days that we like better than CLDI

CLDI Financial Statistics

Sales & Book Value

Annual Sales: $45K
Cash Flow: $-3.84M
Price / Cash Flow: 0
Annual Sales: $-0.41
Price / Book: 0

Profitability

EPS (TTM): -0.75160
Net Income (TTM): $-23.94M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Calidi Biotherapeutics Earnings Forecast

Key Calidi Biotherapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for CLDI have been equal to 35,337.78% of Gross Profit Margin.
  • The Interest Expense is -3.66% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

Calidi Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLDI
Website: calidibio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLDI Technical Analysis vs Fundamental Analysis

Sell
43
Calidi Biotherapeutics (CLDI) is a Sell

Is Calidi Biotherapeutics a Buy or a Sell?